Should a matched sibling donor still be considered the primary option for allogeneic hematopoietic cell transplantation in patients over 50 years of age with myelodysplastic syndrome?

Bone Marrow Transplantation, Published online: 08 May 2023; doi:10.1038/s41409-023-01997-3Should a matched sibling donor still be considered the primary option for allogeneic hematopoietic cell transplantation in patients over 50 years of age with myelodysplastic syndrome?

Source: Bone Marrow Transplantation - May 8, 2023 Category: Hematology Authors: Takaaki Konuma Hidehiro Itonaga Ken Ishiyama Noriko Doki Naoyuki Uchida Masashi Sawa Yuta Katayama Masatsugu Tanaka Yasunori Ueda Makoto Onizuka Shigesaburo Miyakoshi Yukiyasu Ozawa Takahiro Fukuda Ken-ichi Matsuoka Junji Tanaka Takafumi Kimura Tatsuo Ich Source Type: research